Bayer Hits Abbott With Patent Suit Over Humira

By Brendan Pierson

Law360, New York (December 29, 2008, 12:00 AM ET) -- Bayer HealthCare LLC has sued Abbott Laboratories, alleging that Abbott's hugely popular arthritis drug Humira infringes a Bayer patent.

In a complaint filed Wednesday in the U.S. District Court for the Eastern District of Texas, Bayer accused Abbott of infringing U.S. Patent Number 5,654,407, titled “Human anti-TNF antibodies,” by selling Humira in the U.S.

The '407 patent, issued in 1997, describes an antibody that binds to human tumor necrosis factor alpha, a compound involved in inflammatory diseases.

Humira, which was approved by the U.S. Food and...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles